BALAXI PHARMACEUTICALS
|
The Current P/E Ratio of BALAXI PHARMACEUTICALS is 13.45.
Share Price | ₹46.0 | Sep 09,2025 |
Market Cap | ₹254.0 Cr | |
Earnings-TTM | ₹18.9 Cr | TTM-Consolidated Results |
Price/Earnings | 13.45x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of BALAXI PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹254.0 Cr] as on Sep 09,2025
(/) Earnings [ ₹18.9 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 13.45x ]
Thus, for BALAXI PHARMACEUTICALS , the investors are currently willing to pay 13.45 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of BALAXI PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of BALAXI PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of BALAXI PHARMACEUTICALS
PE Ratio Performance Analysis for BALAXI PHARMACEUTICALS
- BALAXI PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 7.25x.
- BALAXI PHARMACEUTICALS 's operated at median p/e ratio of 7.3x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BALAXI PHARMACEUTICALS 's p/e ratio peaked in Mar2021 at 14.09x.
- BALAXI PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does BALAXI PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Trading Industry?
Peer Comparison (Trading Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
BALAXI PHARMACEUTICALS | 18.88 | 13.45 | 254.0 |
ADANI ENTERPRISES LTD | 6,753.29 | 39.51 | 266,824.0 |
REDINGTON LTD | 1,836.56 | 10.35 | 19,008.8 |
MMTC LTD | 74.59 | 129.57 | 9,664.5 |
HONASA CONSUMER LTD | 73.75 | 133.09 | 9,815.7 |
LLOYDS ENTERPRISES LTD | 344.47 | 31.64 | 10,899.6 |
ENTERO HEALTHCARE SOLUTIONS LTD | 117.14 | 43.38 | 5,081.2 |
OPTIEMUS INFRACOM LTD | 62.04 | 90.41 | 5,609.3 |
POLO QUEEN INDUSTRIAL & FINTECH LTD | 2.70 | 646.84 | 1,743.9 |
MSTC LTD | 416.91 | 8.85 | 3,690.7 |
SG MART LTD | 109.44 | 40.75 | 4,459.1 |
Trading Industry Benchmark (Top 10) PE Analysis vs BALAXI PHARMACEUTICALS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 8.85x |
Max industry PE | 646.84x |
Median industry PE | 40.75x |
Average industry PE | 107.99x |
You may also like the below Video Courses